Compare Flux Power Holdings Inc (FLUX) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs Natera Inc. Common Stock — how do they compare? Flux Power Holdings Inc trades at $0.43 (market cap $9.09M), while Natera Inc. Common Stock trades at $393.93 (market cap $57.03B). The key difference: Natera Inc. Common Stock is far larger — about 6273.9× Flux Power Holdings Inc's market cap, and Natera Inc. Common Stock is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 21 Days and Natera Inc. Common Stock for 0 Days on average.
| FLUX | NTRA | |
|---|---|---|
Market Cap | $9.09M | $57.03B |
Volume | 987,225 | 1,131,157 |
Sector | Industrials | Health |
52-Week High | $6.66 | $425.64 |
52-Week Low | $0.41 | $179.42 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $17.29M | $56.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.4652, down 0.04% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported revenue of $66.43 million in 2025 but posted a net loss of $6.67 million, with profitability metrics showing negative ROE and ROA. Recent news highlights acquisition interest from Solidion Technology, which Flux Power's board rejected in October 2026, creating uncertainty around strategic direction.
The outlook remains challenged by persistent losses and declining revenue projections for 2026, though analyst consensus is unanimously bullish with 6 buy ratings. Key risks include execution on profitability, competitive pressures in energy storage, and potential acquisition volatility. The stock's valuation at 0.22 P/S offers potential if operational improvements materialize.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
